Bausch Health Companies | VRX - Ebit


Bausch Health Companies reported $489M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Amgen USD 3.83B 130M Mar/2026
ANI Pharmaceuticals USD 38.71M 9.58M Mar/2026
Aurora Cannabis CAD 7.12M 42.91M Mar/2026
Bausch Health Companies USD 489M 230M Mar/2026
Biogen USD 514.3M 502.8M Mar/2026
Bristol-Myers Squibb USD 3.56B 90M Mar/2026
Canopy Growth CAD -145.65M 132.99M Mar/2026
Corcept Therapeutics USD -49.6M 54.09M Mar/2026
Danaher USD 1.34B 158M Mar/2026
Drreddys Laboratories INR 3.05B 13.32B Mar/2026
Eli Lilly USD 9.78B 792M Mar/2026
Gilead Sciences USD 2.68B 284M Mar/2026
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Novo Nordisk DKK 59.62B 27.24B Mar/2026
Pacira USD 4.62M 1.43M Mar/2026
Perrigo USD 33.6M 50.8M Mar/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 75.49M 7M Mar/2026
Supernus Pharmaceuticals USD -35.25M 49.07M Mar/2026
Vertex Pharmaceuticals USD 1.14B 124.5M Mar/2026
Zoetis USD 842M 7M Mar/2026